Treatment of terminal-phase chronic myelogenous leukemia with intermediate-dose cytarabine and hydroxyurea.

Autor: Lazzarino, M., Morra, E., Brusamolino, E., Alessandrino, E. P., Orlandi, E., Pagnucco, G., Castagnola, C., Bernasconi, P., Merante, S., Bonfichi, M., Castelli, G., Canevari, A., Bernasconi, C.
Zdroj: Hematological Oncology; Nov1991, Vol. 9 Issue 6, p299-305, 7p
Databáze: Complementary Index
Externí odkaz: